About James Demetriades
James Demetriades is chief executive officer of Kairos Ventures, an investment firm. Kairos Ventures backs companies such as Provivi, Inc., which makes pheromone-based products for pest control and crop protection. He was previously managing partner of Kairos Ventures, a title he held in 2017 when the firm led Provivi's Series B financing round.
He is chairman of the board of Provivi, Inc.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name James Demetriades in the role, so the role may have started earlier or lasted longer.
Provivi, Inc. Current
Chairman
2015 – Present · Santa Monica, CA
Pheromone-based crop protection that disrupts pest mating, built for farmers who grow high-acreage crops such as corn, rice and soy.
KV
Kairos Ventures Current
CEO
Managing Partner
Linnaeus Therapeutics, Inc.
Director
2024 – 2026 · Haddonfield, NJ
Develops experimental medicines for people with cancer.
Key Colleagues at Startups
The people James Demetriades works with at each company, as listed on that company's latest Form D.
Provivi, Inc. · Form D/A, Nov 3, 2026
Linnaeus Therapeutics, Inc. · Form D/A, Apr 2, 2026
CA
Chris Arendt
Director
TT
Todd Thomson
Director
PM
Patrick Mooney
CEO and director
JL
John Lepping
Director
MP
Michael Poisel
Director
Foldax, Inc. · Form D, Nov 7, 2023
Scott Huennekens
Director
KC
Ken Charhut
Director
SR
Scott Richland
Director
GW
George Wallace
Director
GC
Greg Casciaro
Executive officer and director
BH
Brant Heise
Director